TBL1XR1 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "TBL1XR1" in English language version.

refsWebsite

Global rank English rank

14nih.gov

4^th place

8doi.org

2^nd place

2ensembl.org

1,626^th place

1,007^th place

1omim.org

4,380^th place

4,305^th place

1waldenstroms.com

low place

1semanticscholar.org

11^th place

8^th place

doi.org

Zhang X, Dormady SP, Basch RS (November 2000). "Identification of four human cDNAs that are differentially expressed by early hematopoietic progenitors". Experimental Hematology. 28 (11): 1286–96. doi:10.1016/S0301-472X(00)00539-7. PMID 11063877.
Zhang J, Kalkum M, Chait BT, Roeder RG (March 2002). "The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2". Molecular Cell. 9 (3): 611–23. doi:10.1016/S1097-2765(02)00468-9. PMID 11931768.
Hunter Z, Tsakmaklis N, Demos M, Kofides A, Xu L, Chan G, et al. (2017). "The Genomic Landscape of MYD88 Wild-Type Waldenström's Macroglobulinemia is Characterized by Somatic Mutations in TBL1XR1, the CBM Complex, and NFKB2" (PDF). Blood. 130 (Supplement 1): 130. doi:10.1182/blood.V130.Suppl_1.4011.4011. S2CID 251168679.
Simpson BS, Camacho N, Luxton HJ, Pye H, Finn R, Heavey S, et al. (August 2020). "Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype". Communications Biology. 3 (1): 440. doi:10.1038/s42003-020-01175-x. PMC 7429505. PMID 32796921.
Fields AP, Justilien V, Murray NR (January 2016). "The chromosome 3q26 OncCassette: A multigenic driver of human cancer". Advances in Biological Regulation. 60: 47–63. doi:10.1016/j.jbior.2015.10.009. PMC 4729592. PMID 26754874.
Daniels G, Li Y, Gellert LL, Zhou A, Melamed J, Wu X, et al. (February 2014). "TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth". Endocrine-Related Cancer. 21 (1): 127–42. doi:10.1530/ERC-13-0293. PMC 3947037. PMID 24243687.
Yoon HG, Chan DW, Reynolds AB, Qin J, Wong J (September 2003). "N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso". Molecular Cell. 12 (3): 723–34. doi:10.1016/j.molcel.2003.08.008. PMID 14527417.
Yoon HG, Chan DW, Huang ZQ, Li J, Fondell JD, Qin J, Wong J (March 2003). "Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1". The EMBO Journal. 22 (6): 1336–46. doi:10.1093/emboj/cdg120. PMC 151047. PMID 12628926.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000177565 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000027630 – Ensembl, May 2017

nih.gov

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: TBL1XR1 transducin (beta)-like 1X-linked receptor 1".
Simpson BS, Camacho N, Luxton HJ, Pye H, Finn R, Heavey S, et al. (August 2020). "Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype". Communications Biology. 3 (1): 440. doi:10.1038/s42003-020-01175-x. PMC 7429505. PMID 32796921.
Fields AP, Justilien V, Murray NR (January 2016). "The chromosome 3q26 OncCassette: A multigenic driver of human cancer". Advances in Biological Regulation. 60: 47–63. doi:10.1016/j.jbior.2015.10.009. PMC 4729592. PMID 26754874.
Daniels G, Li Y, Gellert LL, Zhou A, Melamed J, Wu X, et al. (February 2014). "TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth". Endocrine-Related Cancer. 21 (1): 127–42. doi:10.1530/ERC-13-0293. PMC 3947037. PMID 24243687.
Yoon HG, Chan DW, Huang ZQ, Li J, Fondell JD, Qin J, Wong J (March 2003). "Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1". The EMBO Journal. 22 (6): 1336–46. doi:10.1093/emboj/cdg120. PMC 151047. PMID 12628926.

pubmed.ncbi.nlm.nih.gov

Zhang X, Dormady SP, Basch RS (November 2000). "Identification of four human cDNAs that are differentially expressed by early hematopoietic progenitors". Experimental Hematology. 28 (11): 1286–96. doi:10.1016/S0301-472X(00)00539-7. PMID 11063877.
Zhang J, Kalkum M, Chait BT, Roeder RG (March 2002). "The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2". Molecular Cell. 9 (3): 611–23. doi:10.1016/S1097-2765(02)00468-9. PMID 11931768.
Simpson BS, Camacho N, Luxton HJ, Pye H, Finn R, Heavey S, et al. (August 2020). "Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype". Communications Biology. 3 (1): 440. doi:10.1038/s42003-020-01175-x. PMC 7429505. PMID 32796921.
Fields AP, Justilien V, Murray NR (January 2016). "The chromosome 3q26 OncCassette: A multigenic driver of human cancer". Advances in Biological Regulation. 60: 47–63. doi:10.1016/j.jbior.2015.10.009. PMC 4729592. PMID 26754874.
Daniels G, Li Y, Gellert LL, Zhou A, Melamed J, Wu X, et al. (February 2014). "TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth". Endocrine-Related Cancer. 21 (1): 127–42. doi:10.1530/ERC-13-0293. PMC 3947037. PMID 24243687.
Yoon HG, Chan DW, Reynolds AB, Qin J, Wong J (September 2003). "N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso". Molecular Cell. 12 (3): 723–34. doi:10.1016/j.molcel.2003.08.008. PMID 14527417.
Yoon HG, Chan DW, Huang ZQ, Li J, Fondell JD, Qin J, Wong J (March 2003). "Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1". The EMBO Journal. 22 (6): 1336–46. doi:10.1093/emboj/cdg120. PMC 151047. PMID 12628926.

omim.org

"OMIM Entry - # 602342 - PIERPONT SYNDROME; PRPTS". www.omim.org. Retrieved 2020-04-05.

semanticscholar.org

api.semanticscholar.org

Hunter Z, Tsakmaklis N, Demos M, Kofides A, Xu L, Chan G, et al. (2017). "The Genomic Landscape of MYD88 Wild-Type Waldenström's Macroglobulinemia is Characterized by Somatic Mutations in TBL1XR1, the CBM Complex, and NFKB2" (PDF). Blood. 130 (Supplement 1): 130. doi:10.1182/blood.V130.Suppl_1.4011.4011. S2CID 251168679.

waldenstroms.com

Hunter Z, Tsakmaklis N, Demos M, Kofides A, Xu L, Chan G, et al. (2017). "The Genomic Landscape of MYD88 Wild-Type Waldenström's Macroglobulinemia is Characterized by Somatic Mutations in TBL1XR1, the CBM Complex, and NFKB2" (PDF). Blood. 130 (Supplement 1): 130. doi:10.1182/blood.V130.Suppl_1.4011.4011. S2CID 251168679.